Yogi Care Pharmaceutical Pvt. Ltd. is a privately held Indian pharmaceutical company headquartered at Binori B Square, Sindhu Bhavan Road, Ahmedabad, Gujarat, India, with an affiliated entity, Akshar International Pvt. Ltd., operating in an export and international business capacity. The company positions itself as a fully integrated generic pharmaceutical manufacturer with capabilities spanning formulation development, brand development, and international distribution.

Rather than operating its own manufacturing plant, Yogi Care collaborates with third-party manufacturing facilities that hold certifications including EU-GMP, USFDA, UK-MHRA, CE, and WHO-GMP, ensuring that its finished dosage form products are manufactured to standards appropriate for regulated and semi-regulated export markets. The company’s quality assurance team supervises production at these third-party facilities, with stated emphasis on API and excipient quality, physical product specifications, and compliance with international pharmacopoeial standards.

Yogi Care’s domestic operations cover distribution across India, with the company describing coverage across a wide geographic footprint. Its international export markets include the Democratic Republic of the Congo, Nigeria, Ghana, Uganda, Tanzania, Zambia, and Angola — a portfolio of markets concentrated in Sub-Saharan Africa, where demand for affordable, quality-assured generic medicines is substantial. The company has participated in industry events including IPHEX, India’s international pharmaceutical exhibition.

Key Products and Services

Generic Pharmaceutical Products

• NSAIDs — non-steroidal anti-inflammatory and analgesic formulations
• Antibacterials — broad-spectrum antibiotic formulations across tablet, capsule, and injectable presentations
• Antipsychotics — central nervous system formulations for psychiatric indications
• Corticosteroids — anti-inflammatory steroid formulations
• Gastrointestinal Management — formulations for acid suppression, motility disorders, and related indications
• Anti-Malarials — antimalarial formulations relevant to Sub-Saharan African export markets
• Anti-Tuberculosis — fixed-dose combination and standalone anti-TB formulations
• Respiratory Management — bronchodilators and related respiratory medicines
• Genito-Urinary Management — formulations for urological and gynaecological indications
• Antivirals — antiviral formulations spanning infectious disease indications
• Anti-Obesity — formulations for weight management
• Antifungals — systemic and topical antifungal formulations
• Antihelminthics — antiparasitic formulations suited to tropical disease markets
• Cardiac and Diabetic — cardiovascular and glycaemic management formulations
• Injectables — parenteral formulations across relevant therapeutic areas
• Oncology — oncology formulations

Nutraceuticals

• Nutritional supplement and wellness product range, developed alongside the pharmaceutical portfolio

Brand Development and Customisation

• Country-specific brand development services for international partners and distributors, with product registration support appropriate to each target market

Yogi Care Pharmaceutical operates as a generic medicines brand development and export company within India’s substantial pharmaceutical export ecosystem, targeting primarily the Sub-Saharan African generics market — a region characterised by high disease burden, significant unmet need across infectious and non-communicable disease categories, and active demand for cost-competitive, quality-assured medicines from Indian suppliers. Its asset-light model — leveraging certified third-party manufacturing rather than owned plants — reduces capital requirements and allows flexibility in product range whilst maintaining access to internationally compliant manufacturing standards. The company’s therapeutic portfolio, which spans antibacterials, antimalarials, anti-TB, and antiparasitic medicines alongside broader categories, is well-aligned with the disease profile of its primary export markets.